The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(5-(3,5-Dichloro-4-methoxy-phenyl)-thiophen-2-yl)-(3-hydroxy-phenyl)-methanone ID: ALA4089862
PubChem CID: 137644465
Max Phase: Preclinical
Molecular Formula: C18H12Cl2O3S
Molecular Weight: 379.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1c(Cl)cc(-c2ccc(C(=O)c3cccc(O)c3)s2)cc1Cl
Standard InChI: InChI=1S/C18H12Cl2O3S/c1-23-18-13(19)8-11(9-14(18)20)15-5-6-16(24-15)17(22)10-3-2-4-12(21)7-10/h2-9,21H,1H3
Standard InChI Key: ZHTGNWVMKZKUIM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
23.0625 -11.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8875 -11.7292 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
24.1442 -10.9451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4750 -10.4583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8099 -10.9451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9254 -10.6898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5377 -11.2444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3220 -10.9911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4953 -10.1837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8780 -9.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0960 -9.8861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5767 -12.3960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7563 -12.3087 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9112 -13.1502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4236 -13.8168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7576 -14.5703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5788 -14.6581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0650 -13.9864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7284 -13.2355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2715 -15.2369 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9341 -11.5444 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
26.0478 -8.8226 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.2799 -9.9288 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8930 -10.4808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
3 6 1 0
1 12 1 0
12 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
16 20 1 0
8 21 1 0
10 22 1 0
9 23 1 0
23 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.26Molecular Weight (Monoisotopic): 377.9884AlogP: 5.67#Rotatable Bonds: 4Polar Surface Area: 46.53Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.85CX Basic pKa: ┄CX LogP: 5.74CX LogD: 5.72Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.59Np Likeness Score: -0.38
References 1. Abdelsamie AS, van Koppen CJ, Bey E, Salah M, Börger C, Siebenbürger L, Laschke MW, Menger MD, Frotscher M.. (2017) Treatment of estrogen-dependent diseases: Design, synthesis and profiling of a selective 17β-HSD1 inhibitor with sub-nanomolar IC50 for a proof-of-principle study., 127 [PMID:27852458 ] [10.1016/j.ejmech.2016.11.004 ]